Substance use in people at clinical high-risk for psychosis

BMC Psychiatry

Volumn 14, Issue 1, 2014, Pages

  Russo, Debra A ^a,b,e   Stochl, Jan ^c   Painter, Michelle ^a   Jones, Peter B ^a,b,d   Perez, Jesus ^a,b  

^a CAMBRIDGESHIRE AND PETERBOROUGH NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

^d NIHR Collaborations for Applied Health Research and Care   (United Kingdom)

^e FULBOURN HOSPITAL   (United Kingdom)

Author keywords

Alcohol; Cannabis; High risk; Psychosis8Substance use

Indexed keywords

ADOLESCENT; ADULT; AGE; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; BIPOLAR DISORDER; CANNABIS USE; COHORT ANALYSIS; CONTROLLED STUDY; EMPLOYMENT STATUS; ETHNICITY; FEMALE; FOLLOW UP; GENDER; GENERALIZED ANXIETY DISORDER; HELP SEEKING BEHAVIOR; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTIPLE DRUG ABUSE; OBSESSIVE COMPULSIVE DISORDER; PANIC; POPULATION RESEARCH; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PSYCHOSIS; SOCIAL PHOBIA; SUBSTANCE USE; ADDICTION; ANXIETY DISORDER; CANNABIS ADDICTION; CASE CONTROL STUDY; COMPLICATION; DRINKING BEHAVIOR; PSYCHOLOGY; PSYCHOSES, SUBSTANCE-INDUCED; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; ALCOHOL DRINKING; ANXIETY DISORDERS; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; PSYCHOSES, SUBSTANCE-INDUCED; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84964315089     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-014-0361-1     Document Type: Article

References (27)

1. Yung AR, Yuen HP, Berger G, Francey S, Hung TC, Nelson B, Phillips L, McGorry P: Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull 2007, 33:673-681.
2. Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton MJ, Valmaggia L, Barale F, Caverzasi E, McGuire P: Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry 2012, 69:220-229.
3. Wigman JT, van Nierop M, Vollebergh WA, Lieb R, Beesdo-Baum K, Wittchen HU, van Os J: Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity -implications for diagnosis and ultra-high risk research. Schizophr Bull 2012, 38:247-257.
4. Hui C, Morcillo C, Russo DA, Stochl J, Shelley GF, Painter M, Jones PB, Perez J: Psychiatric morbidity and disability in young people at clinical high risk for psychosis. Schizophr Res 2013, 148:175-180.
5. Kelleher I, Keeley H, Corcoran P, Lynch F, Fitzpatrick C, Devlin N, Molloy C, Roddy S, Clarke MC, Harley M, Arseneault L, Wasserman C, Carli V, Sarchiapone M, Hoven C, Wasserman D, Cannon M: Clinicopathological significance of psychotic experiences in non-psychotic young people: evidence from four population-based studies. Br J Psychiatry 2012, 1:26-32.
6. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK: Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990, 21:2511-2518.
7. McCreadie RG: Scottish Comorbidity Study Group: Use of drugs, alcohol and tobacco by people with schizophrenia: case -control study. Br J Psychiatry 2002, 181:321-325.
8. Barnett JH, Werners U, Secher SM, Hill KE, Brazil R, Masson K, Pernet DE, Kirkbride JB, Murray GK, Bullmore ET, Jones PB: Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psychiatry 2007, 190:515-520.
9. Fergusson DM, Poulton R, Smith PF, Boden JM: Cannabis and psychosis. BMJ 2006, 21:172-175.
10. Dragt S, Nieman DH, Schultze-Lutter F, van der Meer F, Becker H, de Haan L, Dingemans PM, Birchwood M, Patterson P, Salokangas RK, Heinimaa M, Heinz A, Juckel G, Graf von Reventlow H, French P, Stevens H, Ruhrmann S, Klosterkötter J, Linszen DH, EPOS group: Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis. Acta Psychiatr Scand 2012, 125(1):45-53.
11. Addington J, Case N, Saleem MM, Auther AM, Cornblatt BA, Cadenhead KS: Substance use in clinical high risk for psychosis: a review of the literature. Early Interv Psychiatry 2013, doi:10.1111/eip.12100 [Epub ahead of print].
12. Cheng F, Kirkbride JB, Lennox BR, Perez J, Masson K, Lawrence K, Hill K, Feeley L, Painter M, Murray GK, Gallagher O, Bullmore ET, Jones PB: Administrative incidence of psychosis assessed in an early intervention service in England: first epidemiological evidence from a diverse, rural and urban setting. Psychol Med 2011, 41:949-958.
13. Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, Francey SM, Cosgrave EM, Killackey E, Stanford C, Godfrey K, Buckby J: Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry 2005, 39:964-971.
14. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59:22-33.
15. Kay SR, Fiszbein A, Opler LA: The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
16. Compton MT, Kelley ME, Ramsay CE, Pringle M, Goulding SM, Esterberg ML, Stewart T, Walker EF: Relations of Pre-Onset Cannabis, Alcohol, and Tobacco Use with the Age at Onset of Prodrome and Age at Onset of Psychosis in First-Episode Patients. Am J Psychiatry 2009, 166:1251-1257.
17. Phillips P, Johnson S: How does drug and alcohol misuse develop among people with psychotic illnesses? A literature review. Soc Psychiatry Psychiatr Epidemiol 2001, 36:269-276.
18. Hall W, Degenhardt L: Cannabis use and the risk of developing a psychotic disorder. World Psychiatr 2008, 7:68-71.
19. Kamali M, McTigue O, Whitty P, Gervin M, Clarke M, Browne S, Larkin C, O'Callaghan E: Lifetime history of substance misuse in first episode psychosis: prevalence and its influence on psychopathology and onset of psychotic symptoms. Early Interv Psychiatry 2009, 3:198-203.
20. Winters KC: Assessing Alcohol Problems -A Guide for Clinicians and Researchers Second Edition NIH Publication No. 03-3745 Revised 2003 [http://pubs.niaaa.nih.gov/publications/assessingalcohol/index.htm]
21. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel RR: What does the PANSS mean? Schizophr Res 2005, 79:231-238.
22. Addington J, Addington D: Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatr Scand 2007, 115:304-309.
23. Dragt S, Nieman DH, Becker HE, van de Fliert R, Dingemans PM, de Haan L, van Amelsvoort TA, Linszen DH: Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis. Can J Psychiatry 2010, 55:165-171.
24. Korver N, Nieman DH, Becker HE, van de Fliert JR, Dingemans PH, de Haan L, Spiering M, Schmitz N, Linszen DH: Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls. Aust N Z J Psychiatry 2010, 44:230-236.
25. Auther AM, McLaughlin D, Carrión RE, Nagachandran P, Correll CU, Cornblatt BA: Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome. Psychol Med 2012, 42:2485-2497.
26. Nelson B, Yuen H, Wood SJ, Lin A, Spiliotacopoulos D, Bruxner A, Broussard C, Simmons M, Foley DL, Brewerm WJ, Francey SM, Amminger GP, Thompson A, McGorry PD, Yung AR: Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study. JAMA Psychiatr 2013, 70(8):793-802.
27. Barkus E, Murray RM: Substance use in adolescence and psychosis: Clarifying the relationship. Annu Rev Clin Psychol 2010, 6:365-389.